Human T-lymphotropic virus type 1-induced CC chemokine ligand 22 maintains a high frequency of functional FoxP3+ regulatory T cells.
about
How does HTLV-1 cause adult T-cell leukaemia/lymphoma (ATL)?HTLV-1 induces a Th1-like state in CD4+CCR4+ T cells.Leukotrienes are upregulated and associated with human T-lymphotropic virus type 1 (HTLV-1)-associated neuroinflammatory diseaseExpansion in CD39⁺ CD4⁺ immunoregulatory t cells and rarity of Th17 cells in HTLV-1 infected patients is associated with neurological complications.Control of the inflammatory response mechanisms mediated by natural and induced regulatory T-cells in HCV-, HTLV-1-, and EBV-associated cancers.Immunological profile of HTLV-1-infected patients associated with infectious or autoimmune dermatological disordersUnique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profilingFrequency, suppressive capacity, recruitment and induction mechanisms of regulatory T cells in sinonasal squamous cell carcinoma and nasal inverted papilloma.Furin-dependent CCL17-fused recombinant toxin controls HTLV-1 infection by targeting and eliminating infected CCR4-expressing cells in vitro and in vivo.HTLV-1 modulates the frequency and phenotype of FoxP3+CD4+ T cells in virus-infected individuals.Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy.Immunopathogenesis of human T-cell leukemia virus type-1-associated myelopathy/tropical spastic paraparesis: recent perspectivesRisk stratification of adult T-cell leukemia/lymphoma using immunophenotypingCD4+ T cell subsets and Tax expression in HTLV-1 associated diseases.The chemokine system and cancer.Neuroimmunological aspects of human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis.CCR4 and its ligands: from bench to bedside.Cancer immunotherapy: nanodelivery approaches for immune cell targeting and trackingPeripheral T-cell and NK cell lymphoproliferative disorders: cell of origin, clinical and pathological implications.Prevalence of plasma autoantibody against cancer testis antigen NY-ESO-1 in HTLV-1 infected individuals with different clinical statusDirect infection of primary salivary gland epithelial cells by human T lymphotropic virus type I in patients with Sjögren's syndrome.Mycobacterium tuberculosis-specific CD4+ T-cell response is increased, and Treg cells decreased, in anthelmintic-treated patients with latent TB.Human T-cell leukaemia virus type 1: parasitism and pathogenesis.12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy?HTLV-1-associated myelopathy/tropical spastic paraparesis.HTLV-1, the Other Pathogenic Yet Neglected Human Retrovirus: From Transmission to Therapeutic Treatment.Chemokine axis as a therapeutic target to enhance the recruitment of Tregs and treat organ-specific autoimmune and inflammatory diseases
P2860
Q26785554-0E943BB9-BE13-414A-90D2-74BACBB94464Q33944201-C08C8EEC-EE0C-43F6-B59A-E3AAD6B74D25Q34532441-781B28CF-83BD-4139-9B0A-03EF0C0FB5FCQ34587031-13C98FFD-73FB-46F8-AAC4-8A1C23170A5BQ34708248-ED4CD8B7-0152-4114-9594-60D94133DA62Q34927431-60BAD261-6BD3-4075-ADAD-BA325DD70CF1Q35070183-2987B45E-C28F-4766-A440-E9B00919C60CQ35644535-9D4BC18C-05CF-4C3B-AFE1-D83FE3358831Q35984815-C793B147-7B03-47E1-94C6-8CF3A6750670Q36112549-54BBD95D-0381-4B12-B9D5-4605048F34E8Q36147455-9129BBB9-FD4E-4CB5-BF9B-5F8A520E5CD0Q36422111-5E4B8724-6787-4C71-A949-99BF258A9560Q37609458-E714A50C-4112-4B75-BE5A-0CD20274743CQ37726498-661F5D6E-039A-4C01-B4B3-D2F39C75FA43Q37944479-D582BEBA-BEB9-4EEC-9BC2-6DC7F586F0DBQ38128799-7AE7466D-1632-46BC-B39E-777F2E80B68EQ38236403-2022418C-5F93-4217-8252-2F895F378D03Q38288055-5987A475-7749-4077-AE8E-2D7753D4A711Q38289038-50B762FC-D90E-4A14-9DAB-25206B21C3FAQ38675283-6977E2B2-0E32-4175-8DA0-086EB50CAB6AQ38924849-ADD57510-10FF-4D29-AAED-E5BE17005F1EQ39531049-CB4A6DEA-2BE5-4362-810F-D8A989E07350Q40046615-32EB5999-EC1B-4FAD-A322-F11D6D425657Q41883987-41C6F87A-7BE3-46F7-80D1-30187650B8EBQ45096240-5F54A46E-1C01-479F-A7DF-63598AD39C82Q47562043-363A5186-8C3A-4096-8980-DC038A91B47CQ58864595-53E7C52E-B4FF-40CC-A9CD-9957044A64AD
P2860
Human T-lymphotropic virus type 1-induced CC chemokine ligand 22 maintains a high frequency of functional FoxP3+ regulatory T cells.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Human T-lymphotropic virus typ ...... nal FoxP3+ regulatory T cells.
@ast
Human T-lymphotropic virus typ ...... nal FoxP3+ regulatory T cells.
@en
type
label
Human T-lymphotropic virus typ ...... nal FoxP3+ regulatory T cells.
@ast
Human T-lymphotropic virus typ ...... nal FoxP3+ regulatory T cells.
@en
prefLabel
Human T-lymphotropic virus typ ...... nal FoxP3+ regulatory T cells.
@ast
Human T-lymphotropic virus typ ...... nal FoxP3+ regulatory T cells.
@en
P2093
P2860
P50
P356
P1476
Human T-lymphotropic virus typ ...... onal FoxP3+ regulatory T cells
@en
P2093
Graham P Taylor
Kisato Nosaka
Yuetsu Tanaka
P2860
P304
P356
10.4049/JIMMUNOL.0903846
P407
P577
2010-06-04T00:00:00Z